Survey shows high variability in cannabis use across patients with rheumatic disease

An online survey of 1,436 patients with rheumatic disease revealed “significant variability” in cannabis products used, efficacy and side effects, which were driven by several patient-specific factors, according to a study.“Our findings may provide guidance for clinicians and patients in the choice of cannabis products they use, given the wide range of marketed products in

Raccontata dahealio.com